These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38886778)

  • 1. SLC40A1-related hemochromatosis associated with a p.Y333H mutation in mainland China: a pedigree report and literature review.
    Li Y; Duan F; Yang S
    BMC Med Genomics; 2024 Jun; 17(1):161. PubMed ID: 38886778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.
    Chen SR; Yang LQ; Chong YT; Jie YS; Wu YK; Yang J; Lin GL; Li XH
    Intern Med J; 2015 Jun; 45(6):672-6. PubMed ID: 26059880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
    Honma Y; Karasuyama T; Kumamoto K; Shimajiri S; Toki Y; Tatsumi Y; Sumida K; Koikawa K; Morino K; Oe S; Miyagawa K; Yamasaki M; Shibata M; Abe S; Ikuta K; Hayashi H; Harada M
    Med Mol Morphol; 2021 Mar; 54(1):60-67. PubMed ID: 32607777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.
    Zhang W; Lv T; Huang J; Ou X
    Medicine (Baltimore); 2017 Sep; 96(38):e8064. PubMed ID: 28930842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
    Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
    Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports.
    Wu LY; Song ZY; Li QH; Mou LJ; Yu YY; Shen SS; Song XX
    Medicine (Baltimore); 2021 Apr; 100(13):e25258. PubMed ID: 33787609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and acquired cofactors determine phenotypes of ferroportin disease.
    Le Lan C; Mosser A; Ropert M; Detivaud L; Loustaud-Ratti V; Vital-Durand D; Roget L; Bardou-Jacquet E; Turlin B; David V; Loréal O; Deugnier Y; Brissot P; Jouanolle AM
    Gastroenterology; 2011 Apr; 140(4):1199-1207.e1-2. PubMed ID: 21199650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.
    Lee PL; Gelbart T; West C; Barton JC
    Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
    Altès A; Bach V; Ruiz A; Esteve A; Remacha AF; Sardà MP; Felez J; Baiget M
    Ann Hematol; 2009 Apr; 88(4):341-5. PubMed ID: 18820912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Ka C; Guellec J; Pepermans X; Kannengiesser C; Ged C; Wuyts W; Cassiman D; de Ledinghen V; Varet B; de Kerguenec C; Oudin C; Gourlaouen I; Lefebvre T; Férec C; Callebaut I; Le Gac G
    Haematologica; 2018 Nov; 103(11):1796-1805. PubMed ID: 30002125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
    Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.